Medtech company announces its first-ever innovation program in partnering with startups

Medtech News: Multinational medtech companies continue to be hungry in sourcing innovation through partnerships and collaborations to supplement their internal research and development.

Olympus has partnered with MedTech Innovator Asia Pacific, the industry’s largest healthcare accelerator, to present the inaugural Olympus Asia Pacific Innovation Program (OAIP), with the winning innovator to be named at the APACMed MedTech Forum 2023.

Olympus is inviting visionary startups to contribute to this revolution by participating in the OAIP and submitting their technologies that play a meaningful role in the advancement of minimally invasive care and new ways to detect, monitor, and treat conditions and diseases.

Of particular interest are technologies focused on cancers and diseases of the stomach, colon, and lungs, and within the urology specialty. Smart endoscopy, robotics, AI for clinical efficiency and predictive analysis, 3D/4D image reconstruction for surgical procedures and next-generation automated documentation are examples of innovation that is of interest to Olympus.

Felicia Chung, Olympus Business Development Leader for the Asia Pacific, said “I am pleased to announce Olympus’ first-ever Innovation Program that seeks to identify and collaborate with innovators in the very exciting medtech space. APAC is a hotbed of innovative and bold ideas, especially in the space of digital solutions, and we are excited to uncover promising technologies that positively impact human health and create tangible value for providers and patients. We look forward to kick-starting this program and to playing a meaningful role in the advancement of minimally invasive care by identifying new ways to detect, monitor, and treat conditions and diseases.”

Shortlisted startups will be invited to pitch across various in-person and virtual pitch events in front of Olympus executives and leaders over two phases from May 2023 to September 2023, with the winning innovator receiving grant funding of $75,000 as well as an exclusive mentorship program with key thought leaders from within Olympus.

Marc Radatt, CEO for Olympus Corporation of Asia Pacific and board member of the Asia Pacific Medical Technology Association (APACMed), said “Olympus is proud to have partnered with MedTech Innovator Asia Pacific in pursuit of new ideas that will revolutionise patient outcomes and increase access to new technologies through the OAIP. Initiatives like these promote industry wide collaboration, and access to valuable funding and mentorships that result in meaningful change and facilitate greater medtech thought leadership across our region.”

Olympus believes that the emergence of new technologies, particularly those within the digital realm, will revolutionise the patient care paradigm.

To apply for the OAIP, please visit here.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.